Skip to main content

The Globe and Mail

Medicinal pot grower’s ‘purple kush’ product recalled

A man smells a ‘purple kush’ marijuana bud at the The Wonders of Cannabis Festival in San Francisco in October 2007.

Kimberly White/Reuters

A B.C. producer of medical marijuana is voluntarily recalling a batch of one of its products following a Health Canada inspection.

Health Canada says the recall by Greenleaf Medicinals is related to the company's production practices, which may affect its product known as "purple kush."

The Nanaimo, B.C., producer is advising clients to immediately stop using any marijuana from the shipment identified by batch number PK-10-20-13.

Story continues below advertisement

Greenleaf says it is working with other licensed producers to find a supply of purple kush for clients who use the product for medicinal purposes.

Health Canada did not disclose the problems with Greenleaf's production practices nor what adverse effects might occur from smoking the recalled pot.

But the federal department says producers are subject to compliance and enforcement measures similar to those that regulate producers of other controlled substances.

Licensed medical marijuana growers must meet strict security, control and reporting requirements, and are regularly inspected.

Dried marijuana is not an approved drug or medicine in Canada. Possession and use of marijuana remains illegal unless authorized under regulations with the support of a doctor or nurse practitioner, Health Canada said.

Report an error
Comments

The Globe invites you to share your views. Please stay on topic and be respectful to everyone. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

We’ve made some technical updates to our commenting software. If you are experiencing any issues posting comments, simply log out and log back in.

Discussion loading… ✨